OOIR: Observatory of International Research

Papers

(The H4-Index of Liver International is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Issue Information	270
Methylprednisolone‐Induced Liver Injury: Insights From FAERS Analysis and Comparison With DILIN Findings	124
The Relationship Between TNF‐α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic Disorders	116
High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels	115
Navigating portal hypertension: Unlocking safe passage to healthy pregnancy in EHPVO	111
Cardiac Geometry in Cirrhosis: Translation to Public Health and Trial Design	97
RETRACTION : Interferons α, β, γ Each Inhibit Hepatitis C Virus Replication at the Level of Inte	90
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway	86
Correction to ‘Development and Validation of an Image Biomarker to Identify Metabolic Dysfunction Associated Steatohepatitis: MR‐MASH Score’	84
Reply: Herbal‐Induced Liver Injury Identification and Prevention	82
Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients	73
Alcohol‐related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis	71
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population	67
Helicobacter pylori‐Associated Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut Barrier Damage in Liver Cirrhosis	66
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort	65
Prognosis of hospitalized patients with cirrhosis and acute kidney disease	65
Hospitalisations With Cryoglobulin‐Related Diseases in Spain Over 25 Years	64
The integrated stress response‐related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability	63
Impact of socio‐economic environment on incidence of primary liver cancer in France between 2006 and 2016	59
On Evaluating GPT ‐4 for CHB Treatment Recommendations: Reproducibility, Vignette Design and Promp	58
Assessment of PBC Pruritus From the ITCH ‐E Study: Quality of Life, Productivity, and Treatment Ex	57
TIPS Superiority in Refractory Variceal Haemorrhage: Insights From the TIPSEMS ‐ VB	57
Response to Letter to the Editor: “Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression”	51
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease	51
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank	50

HBV cure—The light at the end of the tunnel?	50
Inside Front Cover	48
Is ageing a problematic hurdle to the efficacy of first‐line atezolizumab plus bevacizumab in hepatocellular carcinoma?	47
Letter to the Editor regarding “Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis”	45
Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma	43
Changing epidemiological features of hepatocellular carcinoma: Taiwan's position	43
Is fresh frozen plasma transfusion associated with outcomes in acute variceal bleeding?	41
Think twice about IgG4‐related diseases before operating on hepatic masses	41
Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study	41
Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study	40
Bringing evidence to the MAFLD‐MASLD debate	40
Causal effect of lower birthweight on non‐alcoholic fatty liver disease and mediating roles of insulin resistance and metabolites	39
Association of Liver Disease and Chronic Pruritus: A Case–Control Study	38
Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis	38